[图书][B] The effects of crosstalk between Ras and cyclic AMP-dependent protein kinase A on thyrotropin-mediated signaling pathways

MJ Miller - 1998 - search.proquest.com
The biological response to signal activation depends on the ability of cells to integrate
concomitantly activated signaling pathways. At the molecular level, one of the best …

An in vitro model of thyroid neoplasia: permanently transfected FRTL-5 cells with thyroglobulin promoter-cholera toxin A1 subunit minigene

M Saji, MA Levine, MA Zeiger - Surgery, 1994 - surgjournal.com
Background. Activating mutations of protein Gsa that stimulates adenylyl cyclase are present
in a subset of thyroid adenomas. Cholera loxin A1 subunit (C. T) mimics these mutations via …

[PDF][PDF] Thyroid Cancer and Current Treatment Methods

BC Công - researchgate.net
While researching for this article, I became aware of the prevalence of this disease due to its
presence in two close relatives who were diagnosed a few years ago. Thankfully, both …

Constitutive activation of the Gs alpha protein-adenylate cyclase pathway may not be sufficient to generate toxic thyroid adenomas

M Derwahl, C Hamacher, D Russo… - The Journal of …, 1996 - academic.oup.com
In toxic thyroid adenomas, mutations in the TSH receptor (TSH-R) gene or the gene
encoding the alpha-subunit of the stimulatory guanine nucleotide-binding protein (Gs alpha) …

[PDF][PDF] A fundamental study on the gene therapy of human bladder cancer using the dominant negative H-ras mutant N 116 Y

T WATANABE - Japanese Journal of Veterinary Research, 2001 - eprints.lib.hokudai.ac.jp
44 Information Jpn. 1. Vet. Res. 49 (1),(2001) type 5a showed larger number of granulosa
cells, higher estradiol-17~ production and higher proportion of follicles with TGF-~ 1 positive …

The long non-coding RNA, GHSROS, mediates prostate cancer growth

P Thomas, CM Walpole, P Jeffery… - Clinical …, 2018 - research.usq.edu.au
Long non-coding RNAs (lncRNAs) play key regulatory roles in cancer progression and are
novel therapeutic targets1. We have discovered a lncRNA on the antisense strand of the …

[引用][C] HRAS as a potential therapeutic target of RAS inhibitor salirasib in bladder cancer

杉田智, スギタサトシ - Kagoshima University

Ras mutations are rare in solitary cold and toxic thyroid nodules

K Krohn, A Reske, F Ackermann, A Müller… - Clinical …, 2001 - Wiley Online Library
OBJECTIVE Activation of ras proto‐oncogenes as a result of point mutations is detectable in
a significant percentage of most types of tumour. Similar to neoplasms of other organs …

Persistent ERK/MAPK activation promotes lactotrope differentiation and diminishes tumorigenic phenotype

A Booth, T Trudeau, C Gomez, MS Lucia… - Molecular …, 2014 - academic.oup.com
The signaling pathways that govern the lactotrope-specific differentiated phenotype, and
those that control lactotrope proliferation in both physiological and pathological lactotrope …

H. Maurice Goodman: Basic Medical Endocrinology, 4th edn: Academic Press, New York, NY, 2009

M Susan Smith - 2009 - Springer
The 4th edition of this highly successful textbook continues to have the same focus as
previous editions––the integrative and regulatory roles of the endocrine systems, with upto …